Business Description
Cell Bio Human Tech Co Ltd
ISIN : KR7318160009
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 1.07 | |||||
Interest Coverage | 11.91 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.48 | |||||
Beneish M-Score | -1.16 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3 | |||||
3-Year EBITDA Growth Rate | -38.1 | |||||
3-Year Book Growth Rate | -4.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.49 | |||||
9-Day RSI | 62.2 | |||||
14-Day RSI | 57.4 | |||||
6-1 Month Momentum % | -16.19 | |||||
12-1 Month Momentum % | -5.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.47 | |||||
Quick Ratio | 3.47 | |||||
Days Inventory | 153.82 | |||||
Days Sales Outstanding | 44.58 | |||||
Days Payable | 14.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 6.45 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 27.92 | |||||
Operating Margin % | 15.21 | |||||
Net Margin % | 5.08 | |||||
FCF Margin % | 21.87 | |||||
ROE % | 3.15 | |||||
ROA % | 2.67 | |||||
ROIC % | 5.39 | |||||
ROC (Joel Greenblatt) % | 14.99 | |||||
ROCE % | 10.02 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.69 | |||||
PE Ratio without NRI | 26.15 | |||||
PS Ratio | 1.15 | |||||
PB Ratio | 0.73 | |||||
Price-to-Tangible-Book | 0.72 | |||||
Price-to-Free-Cash-Flow | 5.29 | |||||
Price-to-Operating-Cash-Flow | 4.46 | |||||
EV-to-EBIT | 4.95 | |||||
EV-to-EBITDA | 3.85 | |||||
EV-to-Revenue | 0.8 | |||||
EV-to-FCF | 3.28 | |||||
Price-to-Graham-Number | 0.91 | |||||
Price-to-Net-Current-Asset-Value | 1.79 | |||||
Earnings Yield (Greenblatt) % | 20.18 | |||||
FCF Yield % | 18.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cell Bio Human Tech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 27,816.983 | ||
EPS (TTM) (â‚©) | 145.275 | ||
Beta | 0 | ||
Volatility % | 31.97 | ||
14-Day RSI | 57.4 | ||
14-Day ATR (â‚©) | 199.93063 | ||
20-Day SMA (â‚©) | 3651 | ||
12-1 Month Momentum % | -5.63 | ||
52-Week Range (â‚©) | 2885 - 4865 | ||
Shares Outstanding (Mil) | 8.78 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cell Bio Human Tech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cell Bio Human Tech Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Cell Bio Human Tech Co Ltd Frequently Asked Questions
What is Cell Bio Human Tech Co Ltd(XKRX:318160)'s stock price today?
When is next earnings date of Cell Bio Human Tech Co Ltd(XKRX:318160)?
Does Cell Bio Human Tech Co Ltd(XKRX:318160) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |